47 results on '"Yokoyama, Seiya"'
Search Results
2. MALAT1 functions as a transcriptional promoter of MALAT1::GLI1 fusion for truncated GLI1 protein expression in cancer
3. Gallbladder microbiota composition is associated with pancreaticobiliary and gallbladder cancer prognosis
4. An oncogenic splice variant of PDGFRα in adult glioblastoma as a therapeutic target for selective CDK4/6 inhibitors
5. Exercise Suppresses Head and Neck Squamous Cell Carcinoma Growth via Oncostatin M
6. One-hundred-nm-scale electronic structure and transport calculations of organic polymers on the K computer
7. PCP4/PEP19 downregulates neurite outgrowth via transcriptional regulation of Ascl1 and NeuroD1 expression in human neuroblastoma M17 cells
8. Cervical Cytology Preserves Histologically Detected Surface Epithelial Slackening, Unique to thePOLEMutation-subtype in Endometrial Cancer
9. Novel linear algebraic theory and one-hundred-million-atom quantum material simulations on the K computer
10. Assessment of tumor characteristics based on glycoform analysis of membrane-tethered MUC1
11. Next-generation sequencing analysis of endometrial screening liquid-based cytology specimens: a comparative study to tissue specimens
12. Characterization and treatment of gemcitabine‐ and cisplatin‐resistant bladder cancer cells with a pan‐RAS inhibitor
13. Favorable prognostic impact of phosphatase and tensin homolog alterations in wild-type isocitrate dehydrogenase and telomerase reverse transcriptase promoter glioblastoma
14. Genome Editing Using Cas9 Ribonucleoprotein Is Effective for Introducing PDGFRA Variant in Cultured Human Glioblastoma Cell Lines
15. Molecular Genetic Profile of 300 Japanese Patients with Diffuse Gliomas Using a Glioma-tailored Gene Panel
16. Identification of Neck Lymph Node Metastasis-Specific microRNA—Implication for Use in Monitoring or Prediction of Neck Lymph Node Metastasis.
17. Distribution and favorable prognostic implication of genomicEGFRalterations inIDH‐wildtype glioblastoma
18. Prognostic impact of PDGFRA gain/amplification and MGMT promoter methylation status in patients with IDH wild-type glioblastoma
19. Molecular Evaluation of Endometrial Dedifferentiated Carcinoma, Endometrioid Carcinoma, Carcinosarcoma, and Serous Carcinoma Using a Custom-Made Small Cancer Panel
20. Genome Editing Using Cas9 Ribonucleoprotein Is Effective for Introducing PDGFRA Variant in Cultured Human Glioblastoma Cell Lines.
21. Distribution and favorable prognostic implication of genomic EGFR alterations in IDH‐wildtype glioblastoma.
22. A novel anti-MUC1 antibody against the MUC1 cytoplasmic tail domain: use in sensitive identification of poorly differentiated cells in adenocarcinoma of the stomach
23. Circulating microRNA Panel as a Potential Novel Biomarker for Oral Squamous Cell Carcinoma Diagnosis
24. DNA methylation and histone H3-K9 modifications contribute to MUC17 expression
25. A tailored next‐generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas
26. Predicted Prognosis of Patients with Pancreatic Cancer by Machine Learning
27. The application of methylation specific electrophoresis (MSE) to DNA methylation analysis of the 5' CpG island of mucin in cancer cells
28. Comprehensive validation of liquid-based cytology specimens for next-generation sequencing in cancer genome analysis
29. Immunohistochemical expression of mucin antigens in gallbladder adenocarcinoma: MUC1-positive and MUC2-negative expression is associated with vessel invasion and shortened survival
30. Protective Effects of Peroxiredoxin 4 (PRDX4) on Cholestatic Liver Injury
31. PCP4/PEP19 upregulates aromatase gene expression via CYP19A1 promoter I.1 in human breast cancer SK-BR-3 cells
32. Significant photoresponsivity enhancement of polycrystalline BaSi2 films formed on heated Si(111) substrates by sputtering
33. Erratum: Assessment of tumor characteristics based on glycoform analysis of membrane-tethered MUC1
34. TET1-mediated DNA hypomethylation regulates the expression of MUC4 in lung cancer
35. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas
36. 肺がんを標的とした早期診断・治療応用を目指した基礎的研究
37. A Comprehensive Expression Analysis of Mucins in Appendiceal Carcinoma in a Multicenter Study: MUC3 Is a Novel Prognostic Factor
38. Abstract 1897: Application of a novel DNA methylation analysis method (MSE) for mucin expression in pancreatic juices for diagnosis of pancreatic neoplasms
39. Pathobiological Implications of Mucin (MUC) Expression in the Outcome of Small Bowel Cancer
40. Diagnosis of Pancreatic Neoplasms Using a Novel Method of DNA Methylation Analysis of Mucin Expression in Pancreatic Juice
41. MUC4 and MUC1 Expression in Adenocarcinoma of the Stomach Correlates with Vessel Invasion and Lymph Node Metastasis: An Immunohistochemical Study of Early Gastric Cancer
42. Expression of MUC17 Is Regulated by HIF1α-Mediated Hypoxic Responses and Requires a Methylation-Free Hypoxia Responsible Element in Pancreatic Cancer
43. Epigenetic regulation of mucin genes in human cancers
44. Abstract 82: Expression of MUC17, a marker of pancreatic cancer, is under the control of epigenetic modifications
45. DNA methylation and histone H3-K9 modifications contribute to MUC17 expression
46. Cervical Cytology Preserves Histologically Detected Surface Epithelial Slackening, Unique to the POLE Mutation-subtype in Endometrial Cancer.
47. Molecular Evaluation of Endometrial Dedifferentiated Carcinoma, Endometrioid Carcinoma, Carcinosarcoma, and Serous Carcinoma Using a Custom-Made Small Cancer Panel.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.